Vertex Pharmaceuticals Inc. (VRTX)
Price to Book Value (P/BV)
since 2005
Beginner level
Calculation
Vertex Pharmaceuticals Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Vertex shareholders’ equity1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | 10.68 | = | 185.25 | ÷ | 17.35 | 17.35 | = | 4,435,203 | ÷ | 255,656,889 | |
| Dec 31, 2017 | 20.14 | = | 160.94 | ÷ | 7.99 | 7.99 | = | 2,028,579 | ÷ | 253,891,984 | |
| Dec 31, 2016 | 18.42 | = | 85.73 | ÷ | 4.66 | 4.66 | = | 1,156,582 | ÷ | 248,438,127 | |
| Dec 31, 2015 | 22.38 | = | 85.37 | ÷ | 3.81 | 3.81 | = | 939,967 | ÷ | 246,391,955 | |
| Dec 31, 2014 | 25.60 | = | 113.66 | ÷ | 4.44 | 4.44 | = | 1,075,006 | ÷ | 242,088,884 | |
| Dec 31, 2013 | 14.77 | = | 84.98 | ÷ | 5.75 | 5.75 | = | 1,356,405 | ÷ | 235,771,942 | |
| Dec 31, 2012 | 10.08 | = | 46.17 | ÷ | 4.58 | 4.58 | = | 999,180 | ÷ | 218,188,628 | |
| Dec 31, 2011 | 10.05 | = | 37.60 | ÷ | 3.74 | 3.74 | = | 786,843 | ÷ | 210,335,993 | |
| Dec 31, 2010 | 16.16 | = | 39.85 | ÷ | 2.47 | 2.47 | = | 503,973 | ÷ | 204,412,712 | |
| Dec 31, 2009 | 7.45 | = | 40.70 | ÷ | 5.47 | 5.47 | = | 1,096,346 | ÷ | 200,576,408 | |
| Dec 31, 2008 | 21.09 | = | 33.10 | ÷ | 1.57 | 1.57 | = | 238,874 | ÷ | 152,189,782 | |
| Dec 31, 2007 | 8.92 | = | 18.21 | ÷ | 2.04 | 2.04 | = | 271,295 | ÷ | 132,964,533 | |
| Dec 31, 2006 | 7.52 | = | 30.03 | ÷ | 3.99 | 3.99 | = | 505,935 | ÷ | 126,650,456 | |
| Dec 31, 2005 | 18.12 | = | 39.49 | ÷ | 2.18 | 2.18 | = | 239,176 | ÷ | 109,734,852 |
Based on: 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-11), 10-K (filing date: 2013-03-01), 10-K (filing date: 2012-02-22), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-17), 10-K (filing date: 2008-02-11), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-16).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Vertex Pharmaceuticals Inc.’s Annual Report.
Comparison to Competitors
Vertex Pharmaceuticals Inc., P/BV, long-term trends, comparison to competitors
| Vertex Pharmaceuticals Inc. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | 10.68 | 4.38 | — | 0.71 | 9.41 | 5.03 | 5.89 | 12.87 | 3.89 | 6.08 | 7.79 | 3.80 | 5.07 | 18.74 |
| Dec 31, 2017 | 20.14 | 3.40 | 36.95 | 0.73 | 5.02 | 5.80 | 8.88 | 7.33 | 5.15 | 5.79 | 4.30 | 2.94 | 5.66 | 21.52 |
| Dec 31, 2016 | 18.42 | 3.76 | 21.24 | 1.08 | 4.14 | 4.70 | 5.66 | 6.33 | 4.88 | 4.72 | 4.51 | 3.40 | 8.58 | 17.46 |
| Dec 31, 2015 | 22.38 | 2.68 | 22.17 | 1.54 | 3.94 | 6.31 | 7.04 | 5.51 | 6.59 | 4.07 | 3.15 | 2.84 | 10.53 | 19.72 |
| Dec 31, 2014 | 25.60 | 3.32 | 56.09 | 2.67 | 4.59 | 8.49 | 6.72 | 5.14 | 10.08 | 4.01 | 3.42 | 2.95 | 16.22 | 17.61 |
| Dec 31, 2013 | 14.77 | 2.38 | 18.05 | 4.11 | 4.30 | 8.25 | 5.92 | 3.69 | 11.36 | 3.50 | 3.35 | 2.69 | 16.74 | 15.56 |
| Dec 31, 2012 | 10.08 | 2.06 | 18.06 | 2.84 | 3.57 | 5.34 | 4.40 | 4.15 | 7.01 | 3.29 | 2.44 | 2.42 | 12.91 | 4.15 |
| Dec 31, 2011 | 10.05 | 3.61 | — | 2.15 | 2.83 | 4.53 | 3.50 | 3.35 | 5.08 | 3.13 | 2.14 | 1.95 | 19.19 | — |
| Dec 31, 2010 | 16.16 | 3.24 | — | 2.10 | 2.04 | 2.94 | 2.76 | 3.21 | 5.29 | 2.88 | 1.85 | 1.75 | 6.42 | — |
| Dec 31, 2009 | 7.45 | 3.69 | — | 1.64 | 2.46 | 2.34 | 2.88 | 4.17 | 6.74 | 3.45 | 1.97 | 1.57 | 5.49 | — |
| Dec 31, 2008 | 21.09 | 4.78 | — | 1.44 | 2.48 | 2.69 | 3.29 | 5.01 | 9.83 | 3.56 | 2.72 | 1.44 | 2.94 | — |
| Dec 31, 2007 | 8.92 | 4.83 | — | 1.58 | 2.77 | 3.38 | 4.22 | 4.16 | 11.76 | 4.17 | 5.38 | 2.32 | 3.24 | — |
| Dec 31, 2006 | 7.52 | 5.88 | — | 1.57 | 3.96 | 2.25 | 5.50 | 5.43 | 18.07 | 4.78 | 5.45 | 2.49 | 5.77 | — |
| Dec 31, 2005 | 18.12 | 4.69 | — | 1.56 | 4.26 | 2.27 | 4.00 | 5.85 | 9.18 | 4.66 | 4.30 | 2.94 | 8.16 | — |
Based on: 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-11), 10-K (filing date: 2013-03-01), 10-K (filing date: 2012-02-22), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-17), 10-K (filing date: 2008-02-11), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-16).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Vertex Pharmaceuticals Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Vertex Pharmaceuticals Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2018 | 10.68 | 5.31 |
| Dec 31, 2017 | 20.14 | 4.52 |
| Dec 31, 2016 | 18.42 | 4.09 |
| Dec 31, 2015 | 22.38 | 3.83 |
| Dec 31, 2014 | 25.60 | 4.68 |
| Dec 31, 2013 | 14.77 | 4.17 |
| Dec 31, 2012 | 10.08 | 3.30 |
| Dec 31, 2011 | 10.05 | 2.76 |
| Dec 31, 2010 | 16.16 | 2.38 |
| Dec 31, 2009 | 7.45 | 2.54 |
| Dec 31, 2008 | 21.09 | 2.97 |
| Dec 31, 2007 | 8.92 | 3.70 |
| Dec 31, 2006 | 7.52 | 4.08 |
| Dec 31, 2005 | 18.12 | 3.99 |
Based on: 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-11), 10-K (filing date: 2013-03-01), 10-K (filing date: 2012-02-22), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-17), 10-K (filing date: 2008-02-11), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-16).
Comparison to Industry (Health Care)
Vertex Pharmaceuticals Inc., P/BV, long-term trends, comparison to industry (health care)
| Vertex Pharmaceuticals Inc. | Health Care | |
|---|---|---|
| Dec 31, 2018 | 10.68 | 4.86 |
| Dec 31, 2017 | 20.14 | 4.33 |
| Dec 31, 2016 | 18.42 | 3.89 |
| Dec 31, 2015 | 22.38 | 3.56 |
| Dec 31, 2014 | 25.60 | 4.38 |
| Dec 31, 2013 | 14.77 | 3.86 |
| Dec 31, 2012 | 10.08 | 3.07 |
| Dec 31, 2011 | 10.05 | 2.61 |
| Dec 31, 2010 | 16.16 | 2.32 |
| Dec 31, 2009 | 7.45 | 2.43 |
| Dec 31, 2008 | 21.09 | 2.74 |
| Dec 31, 2007 | 8.92 | 3.54 |
| Dec 31, 2006 | 7.52 | 3.85 |
| Dec 31, 2005 | 18.12 | 4.15 |
Based on: 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-11), 10-K (filing date: 2013-03-01), 10-K (filing date: 2012-02-22), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-17), 10-K (filing date: 2008-02-11), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-16).